We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Grants Teva’s Plan B One-Step Three Years of Exclusivity
FDA Grants Teva’s Plan B One-Step Three Years of Exclusivity
July 26, 2013
The FDA without fanfare last week quietly updated the Orange Book to show that Teva’s Plan B One-Step has been awarded three years of exclusivity, blocking generics through April 30, 2016.